On-treatment function testing of platelets and long-term outcome of patients with peripheral arterial disease undergoing transluminal angioplasty

European Journal of Vascular and Endovascular Surgery

Volumn 42, Issue 6, 2011, Pages 809-816

  Van Der Loo, B ^a   Braun, J ^b   Koppensteiner, R ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Angioplasty; Aspirin; Peripheral arterial disease; Platelet function; Restenosis

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ADRENALIN; COLLAGEN;

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; FEMALE; FOLLOW UP; HEART CATHETERIZATION; HEART INFARCTION; HUMAN; LIGHT TRANSMISSION AGGREGOMETRY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RECURRENT DISEASE; RESTENOSIS; STROKE; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; TREATMENT OUTCOME; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; ANGIOPLASTY; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICOAGULANTS; ASPIRIN; DALTEPARIN; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; ISCHEMIA; LEG; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; PLATELET AGGREGATION; PLATELET FUNCTION TESTS; RECURRENCE; RISK FACTORS; STATISTICS AS TOPIC; TREATMENT OUTCOME;

EID: 81755180532     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2011.08.014     Document Type: Article

References (21)

1. R.F. Storey Variability of response to antiplatelet therapy Eur Heart J Suppl 10 Suppl. A 2008 A21 A27
2. F.M. Gengo, M. Rainka, M. Robson, M.F. Gengo, A. Forrest, and M. Hourihane Prevalence of platelet nonresponsiveness to aspirin in patients treated for secondary stroke prophylaxis and in patients with recurrent ischemic events J Clin Pharmacol 48 2008 335 343 (Pubitemid 351257777)
3. C. Patrono, and B. Rocca Drug insight: aspirin resistance - fact or fashion? Nat Clin Pract Cardiovasc Med 4 2007 42 50 (Pubitemid 44971071)
4. M. Lordkipanidze, C. Pharand, E. Schampaert, J. Turgeon, D.A. Palisaitis, and J.G. Diodati A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease Eur Heart J 28 2007 1702 1708 (Pubitemid 47227104)
5. G. Krasopoulos, S.J. Brister, W.S. Beattie, and M.R. Buchanan Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and meta-analysis Br Med J 336 2008 195 198 (Pubitemid 351212675)
6. B. Pamukcu A review of aspirin resistance: definition, possible mechanisms, detection with platelet function tests, and its clinical outcomes J Thromb Thrombolysis 23 2007 213 222 (Pubitemid 46564122)
7. C. Diehm, A. Schuster, J.R. Allenberg, H. Darius, R. Haberl, and S. Lange High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study Atherosclerosis 172 2004 95 105 (Pubitemid 38058606)
8. C. Diehm, S. Lange, H. Darius, D. Pittrow, B. von Stritzky, and G. Tepohl for the getABI Study Group. Association of low ankle brachial index with high mortality in primary care Eur Heart J 27 2006 1743 1749 (Pubitemid 44025363)
9. Antiplatelet Trialists Collaboration Collaborative overview of randomized trials of antiplatelet therapy. II. Maintenance of vascular graft or arterial patency by antiplatelet therapy Br Med J 308 1994 159 168
10. M.R. Mueller, A. Salat, P. Stangl, M. Murabito, S. Pulaki, and D. Boehm Variable platelet response to low-dose ASA and the risk of limb deterioration in patients submitted to peripheral arterial angioplasty Thromb Haemost 78 1997 1003 1007 (Pubitemid 27417291)
11. R. Koppensteiner, S. Spring, B. Amann-Vesti, T. Meier, T. Pfammatter, and V. Rousson Low-molecular-weight heparin for prevention of restenosis after femoropopliteal percutaneous transluminal angioplasty: a randomized controlled trial J Vasc Surg 44 2006 1247 1253 (Pubitemid 44834599)
12. J.A. Dormandy, and R.B. Rutherford Management of peripheral arterial disease (PAD). TransAtlantic interSociety Consensus (TASC) J Vasc Surg 31 2000 S1 S296
13. F. Santilli, B. Rocca, R. de Cristofaro, S. Lattanzio, L. Pietrangelo, and A. Hybib Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays. Implications for "aspirin resistance" J Am Coll Cardiol 53 2009 667 677
14. A.A. Weber, B. Przytulski, A. Schanz, T. Hohlfeld, and K. Schrör Towards a definition of aspirin resistance: a typological approach Platelets 13 2002 37 40 (Pubitemid 34169586)
15. K.A. Schwartz, D.E. Schwartz, K. Gosheh, J. Reeves, K. Barber, and A. DeFranco Compliance as a critical consideration in patients who appear to be resistant to aspirin after healing of myocardial infarction Am J Cardiol 95 2005 973 975 (Pubitemid 40487749)
16. J. Golanski, S. Chlopicki, R. Golanski, P. Gresner, A. Iwaszkiewicz, and C. Watala Resistance to aspirin in patients after coronary artery bypass grafting is transient. Impact on the monitoring of aspirin antiplatelet therapy Ther Drug Monit 27 2005 484 490 (Pubitemid 41098824)
17. D. Trenk, and F.J. Neumann Aspirin resistance J Am Coll Cardiol 52 2008 740 742
18. A.Y. Gasparyan, T. Watson, and G.Y. Lip The role of aspirin in cardiovascular prevention: implications of aspirin resistance J Am Coll Cardiol 51 2008 1829 1843 (Pubitemid 351615246)
19. R.D. McBane II, K. Karnicki, R.S. Miller, and W.G. Owen The impact of peripheral arterial disease on circulating platelets Thromb Res 113 2004 137 145 (Pubitemid 38534491)
20. J.W. Eikelboom, J. Hirsh, J.I. Weitz, M. Johnston, Q. Yi, and S. Yusuf Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events Circulation 105 2002 1650 1655 (Pubitemid 34298607)
21. D.L. Yee, C.W. Sun, A.L. Bergeron, J.F. Dong, and P.F. Bray Aggregometry detects platelet hyperreactivity in healthy individuals Blood 106 2005 2723 2729 (Pubitemid 41510746)